Click here to see some of the great Resources and Services available to researchers through the ORS. Research Orientations The ORS offers research orientations to both faculty (principal investigators) and non-faculty (clinical research coordinators, managers,...
On July 22, 2022, the revised federal policies for ClinicalTrials.gov took effect, including new penalties for non-compliance. The financial penalty is significant ($13,237 per day of non-compliance), and existing and future NIH funding may be impacted. Specifically,...
Preliminary results from the ACTIV-1 Immune Modulator clinical trial show that immune modulator drugs, infliximab and abatacept, substantially improved clinical status and reduced deaths in adults hospitalized with COVID-19. The National Institutes of Health (NIH)...
ConduITS the Clinical & Translational Science Award (CTSA) Program for the Mount Sinai Health System is proud to announce that one of Mount Sinai’s leading COVID-19 experts Judith A. Aberg, MD, the Chief of Infectious Diseases (ID) for the Mount Sinai Healthcare...
The Office of Research Services (ORS) and ConduITS Institute for Translational Sciences at the Icahn School of Medicine at Mount Sinai has recently added two new CITI Program learning modules for clinical research coordinators (or anyone at Mount Sinai) to access for...
In partnership with the Icahn School of Medicine at Mount Sinai Science magazine recently published a supplement titled “The Frontiers of Medical Research.” The supplement includes 17 articles prepared by Mount Sinai researchers, physicians, and educators that...
As part of its mission to streamline and accelerate translational research ConduITS, the Institutes for Translational Sciences at Mount Sinai CTSA and the Office of Research Services (ORS) offer guidance and services for subject recruitment and retention, which can be...
The U.S. government and the National Institutes of Health (NIH) have growing concerns about inappropriate influence by foreign governments over federally funded research. In response, the NIH has taken a number of steps to address these risks, which include...